462 studies found for:    Open Studies | "Bronchial Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis
Condition: Acute Viral Bronchiolitis
Intervention:
22 Recruiting A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Patients With Uncontrolled Asthma
Condition: Asthma
Interventions: Drug: lebrikizumnab;   Other: placebo
23 Not yet recruiting Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia
Condition: Primary Ciliary Dyskinesia
Intervention: Procedure: Chest physiotherapy
24 Recruiting Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Condition: Asthma
Interventions: Biological: Mepolizumab;   Drug: Placebo;   Drug: SOC
25 Recruiting Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
Conditions: Disorder Related to Lung Transplantation;   Bronchiolitis Obliterans
Intervention:
26 Not yet recruiting A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma
Condition: Asthma
Interventions: Drug: Fluticasone Furoate;   Drug: Vilanterol;   Drug: Fluticasone propionate;   Drug: Salmeterol;   Drug: Budesonide;   Drug: Formoterol Fumarate
27 Recruiting The Comparison of Electronic Auscultation Coupled With Computer Aided Lung Sound Analysis (CALSA) and Functional Respiratory Imaging (FRI) and Repeatability of FRI Biomarkers in Healthy Subjects and Asthma Patients
Condition: Healthy Volunteer, Patient With Asthma
Intervention: Device: CT-scan
28 Unknown  Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
Conditions: Asthma;   Viral Infection
Interventions: Drug: Mepolizumab;   Drug: Placebo
29 Unknown  A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients
Condition: Bronchial Asthma
Interventions: Drug: Keratinocyte Growth factor;   Drug: Saline placebo
30 Not yet recruiting Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.
Condition: Mild to Moderate Persistent Asthma
Intervention: Dietary Supplement: Activation Energy Serum
31 Recruiting Asthma Biomarkers for Predicting Response to Therapy
Condition: Asthma
Intervention: Drug: Budesonide
32 Recruiting Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids
Conditions: ASTHMA;   ALLERGIC RHINITIS
Interventions: Drug: Treatment with any inhaled corticosteroid;   Drug: Treatment with any intranasal glucocorticoid
33 Not yet recruiting Bronchial Thermoplasty: Mechanism of Action and Defining Asthma Phenotype
Condition: Asthma
Intervention: Procedure: Bronchial Thermoplasty
34 Recruiting Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)
Conditions: Rhinosinusitis;   Acute Bronchitis;   Acute Otitis Media;   Pharyngotonsillitis
Intervention: Other: Antibiotic prescription strategies
35 Recruiting Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)
Condition: Asthma
Intervention: Drug: beclomethasone dipropionate
36 Not yet recruiting Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of Bronchiectasis
Condition: Bronchiectasis
Intervention: Drug: Antibiotics
37 Not yet recruiting Low-dose Methotrexate for Reduction GINA 5 Medications in Chronic Severe Asthma
Condition: Low Dose Methotrexate in Severe Chronic Asthma
Interventions: Drug: Methotrexate;   Drug: Placebo
38 Recruiting Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients
Conditions: Asthma;   HIV
Intervention:
39 Recruiting Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma
Condition: Asthma
Intervention: Drug: Magnesium Sulfate
40 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma
Intervention: Drug: Ampicillin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years